PRCHN Tobacco Research Symposium
May 31 | Tinkham Veale, CWRU campus
Registration and light breakfast:
8:00-8:30 am
Program:
8:30-11:30 am
- State of Tobacco in Cleveland and Cuyahoga County
- Tipped, Untipped, Filtered, Flavored: Not Your Grandfather's Cigar
- Understanding and Measuring Nicotine Dependence among Cigarillo Users
- Retail Exposure to Tobacco Advertising and Sales
- Worksite Wellness Initiatives to Support Tobacco Change: Unintended Consequences
- Implementing an Evidence-based Strategy in Primary Care: Ask-Advise-Connect and eReferral
- Breathe Free: We Share Air
|
VeloSano Fundraiser Bash for Team CCC
Jun 2 | TOLI
Join Team Case CCC at TOLI (12117 Mayfield Rd, Cleveland, OH) on Friday, June 2 from 5-8p as we raise money for the 4th Annual VeloSano Bike to Cure! Proceeds from the event go directly towards cancer research in Cleveland.
|
Race for the Place
Jun 4 | Beachwood Place
Walk or run with the
Case CCC team at the Race for the Place, June 4, 2017. This great event helps The Gathering Place to offer services to anyone touched by cancer, no matter their economic situation. Anyone and everyone is welcome to join our team. If you can't make the Race in person, please consider making a donation to support our efforts. Hope to see you there! Questions: Contact Captain Gillian Irwin (
[email protected]).
|
Cancer Stem Cell Retreat
Jun 16 | Cleveland Clinic LRI
The Cancer Stem Cell retreat will foster scientific discovery, facilitate local community collaboration, bridge translational applications, and educate trainees.
Highlights include:
- Keynote presentation by Ronald J. Buckanovich, MD, PhD, University of Michigan
- Industrial talks
- Trainee presentations
- Abstract awards
- Networking lunch
- Poster session and reception
The retreat will be held Friday, June 16 from 9a-6p at the Cleveland Clinic Lerner Research Institute. There is no cost to attend this event, but registration is required.
|
Case CCC Annual Scientific Retreat
Jul 20-21 | CWRU campus
The Case CCC Annual Scientific Retreat will be held July 20-21, 2017. The program is still being finalized, the afternoon of Thursday, July 20 will feature a director's overview by Dr. Stan Gerson, a keynote address by an invited speaker, and a student and trainee poster session.
The program on Friday, July 21 will differ from past years, and will serve as practice for our upcoming NCI site visit. Attendance on this day is only open to invited Cancer Center leaders and key personnel.
More details about the retreat will be posted soon. In the meantime, save the date and encourage your students and trainees to submit abstracts!
|
Call for Abstracts: Mesenchymal Stem Cell (MSC) Conference
Aug 14-16 | Marriott Key Center, Downtown
The National Center for Regenerative Medicine (NCRM) invites you to submit an abstract for the upcoming 2017 MSC Conference.
The following will be selected from submissions:
Short talks;
Lightning talks;
Young Investigator award;
Best Abstract award.
Abstract Categories:
- MSC Sources for Derivation
- Disease Models for Adult Stem Cell Therapy
- Immunomodulation Using Adult Stem Cells
- Gene Therapy on Adult Stem Cells
- Regenerative Medicine and Adult Stem Cells
- Tissue Engineering
- Cell Biology in the Clinical Setting
- Clinical Trials (Academic & Corporate)
- MSC Technologies
Deadlines
Awards or Short talks: June 2 Rolling submission: Jul 21
|
International Cancer Education Conference
Sep 13-15 | Westin Cleveland Downtown
The International Cancer Education Conference is the only meeting in North America totally dedicated to cancer education - ranging from medical professionals to patients and community education. We invite you to submit an abstract and attend this meeting of national and international specialists in cancer education, survivorship and palliative care focused on advocacy, scientific investigation, program and curriculum development, skill training, and evaluation. National leaders will be presenting special programs on grant writing (National Cancer Institute), cancer and the elderly (Cancer and Aging Research Group), surgical oncology (American College of Surgeons), plus dedicated mentoring opportunities will be available to present to content experts.
|
Graft versus Host Disease National Symposium
Oct 13 | Grand Event Center - Columbus
The GvHD National Conference focuses on cutting edge research and new treatments, consists of two tracks: one for physicians and other health care professionals, and one for BMT survivors, their families and their caregivers. The Meredith A. Cowden Foundation in collaboration with the Case CCC, UH Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute, created the National GvHD Health Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment. Over 1,200 people have attended this event, which provides an opportunity for attendees to interact with some of the world's leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients. This year we are excited to team up with the The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute as hosts of the 2017 symposium! CME credits will be offered.
|
- Idea Development Award
[LOI: Jul 13; Application: Oct 5]
- Era of Hope Scholar Award
[LOI: Jun 8; Application: Jun 15]
- Innovator Award
[LOI: Jun 9; Application: Aug 31]
- Breakthrough Award Levels 1 and 2
[LOI: Jun 8; Application: Jun 15]
- Breakthrough Award Levels 3 and 4
[LOI: Jun 8; Application: Jun 15]
- Distinguished Investigator Award
[LOI: Jun 9; Application: Aug 31]
- Breakthrough Fellowship Award
[LOI: Jun 8; Application: Jun 15]
- Concept Award
[LOI: Jul 22; Application: Aug 10]
- Career Development Award
[LOI: Sep 13; Application: Sep 27]
- Idea Development Award
[LOI: Jun 28; Application: Sep 27]
- Investigator Initiated Translational Research Award
[LOI: Jun 28; Application: Sep 27]
- Translational Research Partnership Award
[LOI: Jun 28; Application: Sep 27]
- Clinical Development Award
[LOI: Jun 21; Application: Sep 6]
- Investigator-Initiated Research Award
[LOI: Jun 21; Application: Sep 6]
- Ovarian Cancer Academy Award - Early-Career Investigator
[LOI: Jun 21; Application: Sep 6]
- Pilot Award
[LOI: Jun 14; Application: Aug 24]
- Idea Award with Special Focus
[LOI: Jun 30; Application: Sep 28]
- Translational Team Science Award
[LOI: Jun 30; Application: Sep 28]
|
Susan G. Komen Breast Cancer Research Career Catalyst Research Grants
Deadline: Jun 7
Early Career breast cancer researchers anywhere in the world are invited to apply for
Komen Career Catalyst Research Grants.
These Komen Training and Career Development awards seek to bridge the funding gap faced by faculty as they start their careers in breast cancer research. Grants funded by Komen provide the preparation necessary to compete for independent funding as an established and successful breast cancer researcher.
There are two focus areas for the FY18 Career Catalyst Research Award: New Treatments for Drug-Resistant Breast Cancers and New Approaches to Combat Metastatic Breast Cancer.
|
Eppendorf & Science Prize for Neurobiology
Deadline: Jun 15
The annual Eppendorf & Science Prize for Neurobiology is an international award which honors young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. The winner and finalists are selected by a committee of independent scientists, chaired by Science's Senior Editor, Dr. Peter Stern. Researchers who are not older than 35 years are invited to apply.
|
NCCN Breast Cancer Quality Initiative Request for Proposals
Deadline: Jun 26
The National Comprehensive Cancer Network (NCCN) is collaborating with Pfizer's Independent Grants for Learning & Change (IGLC) team to offer a new grant opportunity seeking proposals that use clinical pathways to address a quality improvement initiative along the continuum of care for breast cancer patients.
|
Lung Cancer Research Foundation
Deadline: Jul 1
Investigators from US and international institutions are eligible to apply for LCRF funding. Individuals must be affiliated with a non-profit academic or research institution and fall into one of the following categories:
- Students and fellows
- Young and mid-career investigators with less than ten years' experience since initial faculty appointment
- Non-tenure track researchers, staff scientists, and clinicians
Senior investigators with more than ten years' experience since faculty appointment are not eligible for LCRF funding but are encouraged to mentor a junior team member through the application process.
|
St. Baldrick's Foundation LOI Deadline: Jul 7 The St. Baldrick's Foundation announces 2018 Fellowships and the opening of the Fall 2017 infrastructure grant cycle.
Infrastructure Grants: Fall grants are not for a specific research project, but rather for resources to allow more research to be done. They support institutions with the potential for more participation in childhood cancer clinical trials, but which currently lack the necessary resources (primarily support for Clinical Research Associates).
Fellowship Awards:
St. Baldrick's Fellowships are granted for 3rd and 4th, or 4th and 5th years of pediatric oncology research, with an opportunity for one additional year of funding based upon need, significant accomplishment and approved application.
|
Case CCC Funding for Pilot/Phase I Clinical Trials
Deadline: Rolling
The Case CCC is encouraging investigators to submit Letters of Intent (LOI) for
Early Phase Clinical Research Support (EPCRS) funding. These in-house funds are available for the conduct of early phase clinical trials of relatively short duration. Priority will be given to trials which are developed jointly between UH and CCF with planned accrual at both institutions.
The proposals are being accepted on a rolling basis subject to availability of funds.
Please direct any questions and/or submit LOIs to Katarzyna Karelus, Case CCC Clinical Research Office,
[email protected], 216.844.4176.
|
NIH BULLETIN- Notices and Funding Opportunities
|
Cancer Moonshot
Deadline: Jun 16, 2017
Deadline: Dec 13, 2017
|
|
|
FOLLOW US
|
VELOSANO 2017
Jul 21-23, 2017
Ride with Us!
Fundraiser Bash!
Fri, Jun 2 5-8p at TOLI (Tavern of Little Italy)
Tickets are $35, and include 2 drinks, raffle ticket, heavy apps and live music!
|
EVENTS
|
Tues, May 30
Radiation Oncology Grand Rounds
William Annable, MD
Chief Quality Officer and Director of the Quality Institute; Interim Chief Medical Officer, University Hospitals Cleveland Medical Center
"Peer Review and Quality Assurance: Are they the same thing?
8:10a Lerner B-151
|
Wed, May 31
PRCHN Tobacco Research Symposium
8-11:30a Tinkham Veale Univ Center
Immunology Faculty Research in Progress Series
Kurt Runge, PhD
Staff, Immunology, Cleveland Clinic
"Tales of Breaks and Chromosome Ends: MRN, NHEJ, Telomere Formation and Searching for the Mechanism of Checkpoint Suppression"
12p NC1-202
Genomic Medicine Institute
Davendra Sohal, MD, MPH
Director, Clinical Genomics Program, Cleveland Clinic
"Tumor Genomic Profiling: Current Status, Future Directions"
5p Q1-300
|
Thurs, Jun 1
Developmental Therapeutics Journal Club 9a R4-013
|
Fri, Jun 2
VeloSano Fundraiser Bash for Team CCC
5-8p TOLI (12117 Mayfield Rd)
Details
|
Sun, Jun 4
Race for the Place - benefits The Gathering Place
8a Beachwood Place (
26300 Cedar Road)
|
Tues, Jun 6
William Schiemann, PhD Professor, Oncology, CWRU "Metastatic Latency in Breast Cancer: Let Sleeping Dogs Lie" 2p NC1-202 |
Thurs, Jun 8
CFAR Leaders Seminar Eric Freed, PhD Director, HIV Dynamics and Replication Program; Head, Virus-Cell Interaction Section, National Cancer Institute, NIH "HIV assembly, release and maturation" 1p SOM W203 |
Fri, Jun 9
Taussig Cancer Institute Grand Rounds Ian Tannock, MD University of Toronto "A Critical Overview of Clinical Studies of Men with Prostate Cancer" 8a R3/002-003
Cellular and Molecular Medicine Guest Speaker Marvin Nieman, PhD Assistant Professor, Pharmacology, CWRU "The molecular basis of protease signaling on cells. Lessions learned from the dynamics of PAR4 activation" 10a NC1-202
|
ADDITIONAL UPCOMING SYMPOSIUMS & EVENTS
Hyaluronan Cleveland 2017
Jun 11-15, 2017
InterContinental Hotel
Cancer Stem Cell Retreat
Jun 16, 2017
Cleveland Clinic
AACI Clinical Research Initiative Meeting
Jul 12-13, 2017
Loews Chicago O'Hare Hotel
Deadline to submit abstracts: May 9
Details
Mesenchymal Stem Cell Conference 2017
Aug 14-16, 2017
Marriott Key Center
Deadline to submit abstracts: Jun 2
International Cancer Education Conference
Sep 13-15, 2017
Westin Cleveland Downtown
GvHD National Symposium
Oct 13, 2017
Grand Event Center, Columbus, OH
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Deadline: Open
Deadline: Open
Deadline: Open
|
|
|
|